CONMED completed the acquisition of In2Bones Global for $255m.

CONMED, a medical technology company, completed the acquisition of In2Bones Global, a global developer, manufacturer, and distributor of medical devices, for $255m. "This acquisition is a natural strategic extension of our Orthopedic portfolio. In2Bones is an exciting platform for CONMED to enter the extremities market given its broad portfolio, extensive sales channel, and experienced leadership team. We look forward to welcoming the In2Bones team to CONMED," Curt R. Hartman, CONMED Chair of the Board, President and CEO.